Israel -
heprea -
Ministry of Health
פרבליפ 10
unipharm ltd, israel - pravastatin sodium - טבליה - pravastatin sodium 10 mg - pravastatin
Israel -
heprea -
Ministry of Health
וינדמקס
pfizer pharmaceuticals israel ltd - tafamidis - קפסולות ג'לטין רכות - tafamidis 61 mg - tafamidis
Israel -
heprea -
Ministry of Health
סינטרדיוס
kamada ltd, israel - prednisolone as sodium phosphate - תמיסה - prednisolone as sodium phosphate 1 mg/ml - prednisolone
Israel -
heprea -
Ministry of Health
סילדזן
taro international ltd, israel - sildenafil as citrate - תרחיף - sildenafil as citrate 25 mg / 1 ml - sildenafil
Israel -
heprea -
Ministry of Health
סיגניפור לאר 10 מג
medison pharma ltd - pasireotide as pamoate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as pamoate 10 mg/vial - pasireotide
Israel -
heprea -
Ministry of Health
סיגניפור לאר 30 מג
medison pharma ltd - pasireotide as pamoate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as pamoate 30 mg/vial - pasireotide
Israel -
heprea -
Ministry of Health
אבילק סירופ
padagis israel pharmaceuticals ltd, israel - lactulose - סירופ - lactulose 66.7 g / 100 ml - lactulose - lactulose - constipation. acute and chronic hepatic encephalopathy.
Israel -
heprea -
Ministry of Health
לשקוטאן משחה
teva israel ltd - methylbenzethonium chloride; paromomycin as sulfate - משחה - methylbenzethonium chloride 12 %w/w; paromomycin as sulfate 15 %w/w - paromomycin - paromomycin - topical treatment of cutaneous leishmaniasis.
Israel -
heprea -
Ministry of Health
טרג'נטה
boehringer ingelheim israel ltd. - linagliptin - טבליות מצופות פילם - linagliptin 5 mg - linagliptin - linagliptin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Israel -
heprea -
Ministry of Health
בייאטה 5 מק"ג
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.